Silymarin & L-Ornithine L-Aspartate with Multivitamin Capsules
Get Price Quote
500 Box (MOQ)
L-Ornithine, L- Aspratate
260 Per Box
50 Box (MOQ)
USES:- People use L-ornithine-L-aspartate for reduced brain function due to advanced liver disease (hepatic encephalopathy). It is also used for athletic performance, cirrhosis, and other purposes, but there is no good scientific evidence to support these uses.
Best Deals from Ornithine L Aspartate
HepCare Capsules
Get Price Quote
100 Strip (MOQ)
L-Ornithine -L-Aspartate 250 MG Convert ammonia in non toxic. Urea through urea cycle. Improve liver Function Test Serum bilirubin . Improve symptoms in week period of time.
Ornithine L Aspartate
300 - 400 Per Box
10 Box (MOQ)
People use L-ornithine-L-aspartate for reduced brain function due to advanced liver disease (hepatic encephalopathy). It is also used for athletic performance, cirrhosis, and other purposes, but there is no good scientific evidence to support these uses
Lomrish Tablets
150 Per Pack
Ornithine L Aspartate
1,450 Per Box
Satliv-70 Injection 10ml
54 - 72 Per Per
100 1000 (MOQ)
L-Ornithine L-Aspartate Infusion
L Ornithine L Aspartate
Get Price Quote
Angeoliv Tablets
Get Price Quote
100 Pack (MOQ)
NUTRIGROW LOVOL-S
58 Per Sachet
2000 Sachet (MOQ)
L-ORNITHINE L-ASPARTATE
1,550 - 1,650 Per Pack
100 Kilogram (MOQ)
L-Ornithine L-Aspartate
Get Price Quote
Silymarin and L-Ornithine L-Aspartate Soft gelatin Capsules, Naproxen Tablets
Ornithine L Aspartate
185 Per Bottle
ETHILIV Injection
Get Price Quote
L-Ornithine L-Aspartate Silymarin Capsule
102 Per Strip
Ornithine L Aspartate
170 Per Box
Ornithine L Aspartate
16 Per unit
Ornithine L Aspartate
2,800 Per Box
Ornithine L Aspartate
1,800 Per Box
L-ornithine-L-aspartate
Get Price Quote
Abstract BACKGROUND/AIMS: In the current state of knowledge of the pathophysiology of hepatic encephalopathy, a reduction in hyperammonemia is the most important evidence of effective treatment. Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves impaired ammonia detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.